| Serial Number | 87671420 |
| Word Mark | EVOLVE BIOLOGICS |
| Filing Date | Friday, November 3, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 23, 2021 |
| Registration Number | 6297746 |
| Registration Date | Tuesday, March 23, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 5, 2021 |
| Goods and Services | Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics |
| Goods and Services | Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods |
| Goods and Services | Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate |
| Goods and Services | Construction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities |
| Goods and Services | Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment |
| NOT AVAILABLE | "BIOLOGICS" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 14, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 037 - Building construction; repair; installation services. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 14, 2017 |
| Primary Code | 037 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 14, 2017 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 14, 2017 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 14, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Evolve Biologics Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Mississauga, Ontario L5N 8G6 CA |
| Party Name | Therapure Biopharma Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Mississauga, Ontario L5N8H9 CA |
| Party Name | Therapure Biopharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Mississauga, Ontario L5N8H9 CA |
| Event Date | Event Description |
| Tuesday, November 7, 2017 | NEW APPLICATION ENTERED |
| Tuesday, November 14, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 14, 2018 | ASSIGNED TO EXAMINER |
| Friday, February 16, 2018 | NON-FINAL ACTION WRITTEN |
| Friday, February 16, 2018 | NON-FINAL ACTION E-MAILED |
| Friday, February 16, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 24, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 2, 2018 | ASSIGNED TO LIE |
| Wednesday, May 9, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 9, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 9, 2018 | SUSPENSION LETTER WRITTEN |
| Wednesday, May 9, 2018 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, May 9, 2018 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, November 14, 2018 | SUSPENSION INQUIRY WRITTEN |
| Wednesday, November 14, 2018 | INQUIRY TO SUSPENSION E-MAILED |
| Wednesday, November 14, 2018 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Thursday, May 9, 2019 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, May 16, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 16, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, May 18, 2019 | SUSPENSION LETTER WRITTEN |
| Saturday, May 18, 2019 | LETTER OF SUSPENSION E-MAILED |
| Saturday, May 18, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, October 30, 2019 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Monday, November 18, 2019 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, November 19, 2019 | SUSPENSION INQUIRY WRITTEN |
| Tuesday, November 19, 2019 | INQUIRY TO SUSPENSION E-MAILED |
| Tuesday, November 19, 2019 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Wednesday, November 27, 2019 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, January 1, 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Friday, January 10, 2020 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, January 14, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 14, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 14, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, January 27, 2020 | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST |
| Tuesday, January 28, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, February 12, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 12, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 12, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 25, 2020 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Monday, July 6, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, July 6, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, July 6, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 24, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 24, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 25, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 26, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, November 30, 2020 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, December 16, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 5, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 5, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 23, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, July 1, 2021 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, July 7, 2021 | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED |
| Monday, March 23, 2026 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |